Table 2

Expression of apoptosis-related markers in CD3+CD8+ T cells of patients with active disease stratified according to the disease status *

Units%RatioMESF × 103
ANX+CD95+Bax/Bcl-2Bcl-XLBax
Disease stage
 I or II32 ± 12 (n = 17)70 ± 19 (n = 17)0.32 ± 0.05 (n = 8)41 ± 12 (n = 8)31 ± 6 (n = 8)
 III or IV47 ± 20 (n = 25)76 ± 14 (n = 25)0.42 ± 0.13 (n = 13)53 ± 17 (n = 13)40 ± 14 (n = 13)
T stage
 T1 or T233 ± 13 (n = 26)72 ± 16 (n = 26)0.35 ± 0.05 (n = 15)46 ± 17 (n = 15)35 ± 12 (n = 15)
 T3 or T437 ± 23 (n = 16)76 ± 17 (n = 16)0.46 ± 0.16 (n = 6)53 ± 14 (n = 6)40 ± 12 (n = 6)
N stage
 N031 ± 13 (n = 24)72 ± 18 (n = 24)0.31 ± 0.05 (n = 10)41 ± 10 (n = 10)31 ± 5 (n = 10)
 N1, N2, N340 ± 21 (n = 18)75 ± 14 (n = 18)0.43 ± 0.013 (n = 11)55 ± 18 (n = 11)42 ± 14 (n = 11)
  • * The data are means ± SD. The numbers of patients studied are in parentheses.

  • Indicates a significant difference (P < 0.05) between patients with or without nodal involvement.